Free Daily Analysis
Stock Trend Analysis Report
Prepared for you on Tuesday, December 2, 2025.
BridgeBio Pharma, Inc. (NASDAQ:BBIO)
Long-Term Uptrend (+90) - BBIO is in a strong uptrend that is likely to continue. While BBIO is showing intraday weakness, it remains in the confines of a bullish trend. Traders should use caution and utilize a stop order.
Is it time to buy, sell, or avoid BBIO?
MarketClub looks at technical strength and momentum to determine if the timing is right for BBIO.
Learn more about the Trade Triangles and how we make technical analysis as easy as buy and sell.
|
|||||||||||||||
|
|||||||||||||||
MarketClub’s Trade Triangles for BBIO
The long-term trend has been UP since Jan 13th, 2025 at 30.51
The intermediate-term trend has been UP since Oct 6th, 2025 at 53.92
The short-term trend has been UP since Nov 6th, 2025 at 64.19
Smart Scan Analysis for BBIO
Based on our trend formula, BBIO is rated as a +90 on a scale from -100 (Strong Downtrend) to +100 (Strong Uptrend).
| Open | High | Low | Price | Change |
|---|---|---|---|---|
| 72.1700 | 73.4500 | 71.4096 | 71.7250 | -0.0550 |
| Prev. Close | Volume | Bid | Ask | Time |
| 71.7800 | 1636423 | 2025-12-02 15:18:05 |
| 52wk High | 72.47 | 52wk High Date | 2025-12-01 |
| 52wk Low | 25.34 | 52wk Low Date | 2024-12-19 |
| Average Volume | 2,207,718 | Shares Outstanding | 192,709 |
| Market Cap | 3,146M | Assets | 998,250,000M |
| Liabilities | 293,132,000M |